R Squared’s Amicus Therapeutics FOLD Stock Holding History

R Squared’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,178	Closed	-$219K	–	592
2026 Q1	$219K	Buy	15,178 +1,390	+10%	+$19.9K	0.12%	293
2025 Q4	$196K	Sell	13,788 -12,036	-47%	-$118K	0.09%	368
2025 Q3	$203K	Buy	25,824 +11,636	+82%	+$82.8K	0.09%	377
2025 Q2	$81.3K	Buy	+14,188	New	+$91.6K	0.04%	364
2025 Q1	–	Sell	-8,410	Closed	-$79.2K	–	722
2024 Q4	$79.2K	Buy	+8,410	New	+$87.4K	0.08%	330

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

R Squared's FOLD Position: Q2 2026 in Review

R Squared sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 15,178 shares — an estimated $219K sold.

R Squared first reported a position in FOLD in Q4 2024 and held it in 5 quarters. The position peaked at $219K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

R Squared reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
R Squared sold 15,178 Amicus Therapeutics shares in Q2 2026, an estimated $219K.
R Squared first reported a position in Amicus Therapeutics in Q4 2024 and held it in 5 quarters.
R Squared's Amicus Therapeutics position peaked at $219K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.